Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daratumumab + VTD in newly diagnosed multiple myeloma (Cassiopeia)
NCT02541383Phase 3Completed
- Start
- Sep 2015
- Primary completion
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 3 trial of daratumumab in multiple myeloma (MM). Started Sep 2015; status: completed.
02
Drugs
daratumumab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02541383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02541383.